BIOTECH: FLUSH WITH $57 MILLION IN VENTURE CAPITAL, A2 BIOTHERAPEUTICS SEEKS A NEW WAY TO KILL CANCER CELLS.
Cell Startup
Monday, November 25, 2019
A2 Biotherapeutics, based in Agoura Hills, came on the biotech startup scene earlier this month after more than a year in stealth mode, nabbing $57 million in Series A funding...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in

- 26 biweekly issues
- Subscriber-only digital content for prime stories
- Book of Lists — the most comprehensive business resource in the Valley region